Archived Diabetes Press Releases: Press releases related to Diabetes that are over 30 days old, but which still contain important Diabetes information for people with Diabetes, Diabetes doctors and other Diabetes health providers.

Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-020 for Type 2 Diabetes
Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-020 for Type 2 Diabetes Jun 17, 2008 SAN DIEGO-- Akesis Pharmaceuticals, Inc. (OTCBB: AKES), an emerging diabetes dr
Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-...
DISCOVERY LEADS TO EARLIER DIAGNOSIS OF TYPE 1 DIABETES
DISCOVERY LEADS TO EARLIER DIAGNOSIS OF TYPE 1 DIABETES MILWAUKEE (4/16/2008) - Researchers identify molecular signature in human type 1 diabetes Researchers at Children's Research Institute,
http://www.chw.org/display/PPF/DocID/28018/AreaID/...
Discovery of new signal pathway important to diabetes research
Discovery of new signal pathway important to diabetes research [Press Release 2008-06-04] Scientists at Karolinska Institutet and Miami University have discovered that cells in the pancreas coopera
http://ki.se/ki/jsp/polopoly.jsp...
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting Knockout Animal Model Findings Validate GhrelinÌs Role as a Key Metabolic Regulator and Demonstr
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Associat...
Medtronic Announces FDA Clearance of New OneTouch? UltralinkÙ Blood Glucose Meter
Medtronic Announces FDA Clearance of New OneTouch? UltralinkÙ Blood Glucose Meter Medtronic and LifeScan to Co-Market Integrated Diabetes Management System with Wireless Blood Glucose Data Transm
Medtronic Announces FDA Clearance of New OneTouch? UltralinkÙ Blood Glucose Met...
OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical Compounds, PSN821 and PSN602, at Annual Meeting of the American Diabetes Association
OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical Compounds, PSN821 and PSN602, at Annual Meeting of the American Diabetes Association MELVILLE, N.Y.--(BUSINESS WIRE)--June 10, 2008--OSI
OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical Compounds, PSN821 and ...
Potential for Sensitive Blood Test to Identify Type-1 Diabetes
Potential for Sensitive Blood Test to Identify Type-1 Diabetes Libraries Medical News Keywords TYPE-1 DIABETES, ADA, T-CELL, ORAL INSULIN, DIAGNOSTIC TEST, GAD65 Contact Information Availab
http://www.newswise.com/articles/view/541495/